Nenad Maćešić

2.1k total citations · 1 hit paper
41 papers, 1.0k citations indexed

About

Nenad Maćešić is a scholar working on Molecular Medicine, Clinical Biochemistry and Infectious Diseases. According to data from OpenAlex, Nenad Maćešić has authored 41 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Medicine, 13 papers in Clinical Biochemistry and 12 papers in Infectious Diseases. Recurrent topics in Nenad Maćešić's work include Antibiotic Resistance in Bacteria (24 papers), Bacterial Identification and Susceptibility Testing (13 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Nenad Maćešić is often cited by papers focused on Antibiotic Resistance in Bacteria (24 papers), Bacterial Identification and Susceptibility Testing (13 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Nenad Maćešić collaborates with scholars based in Australia, United States and United Kingdom. Nenad Maćešić's co-authors include Anne‐Catrin Uhlemann, Medini K. Annavajhala, Angela Gomez‐Simmonds, Marla J. Giddins, Stephania Stump, Anton Y. Peleg, Thomas H. McConville, Sabrina Khan, Nicholas P. Tatonetti and Monica Mehta and has published in prestigious journals such as The Lancet, Nature Communications and PLoS ONE.

In The Last Decade

Nenad Maćešić

39 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multidrug-resistant Gram-negative bacterial infections

2025 48 citations Nenad Maćešić, Anne‐Catrin Uhlemann et al. The Lancet profile →

Peers

Countries citing papers authored by Nenad Maćešić

Since Specialization

Citations

This map shows the geographic impact of Nenad Maćešić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nenad Maćešić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nenad Maćešić more than expected).

Fields of papers citing papers by Nenad Maćešić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nenad Maćešić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nenad Maćešić. The network helps show where Nenad Maćešić may publish in the future.

Co-authorship network of co-authors of Nenad Maćešić

This figure shows the co-authorship network connecting the top 25 collaborators of Nenad Maćešić. A scholar is included among the top collaborators of Nenad Maćešić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nenad Maćešić. Nenad Maćešić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rational design of a hospital-specific phage cocktail to treat Enterobacter cloacae complex infections 2025 ·Nature Microbiology ·Dinesh Subedi, Fernando Gordillo Altamirano, (unknown), (unknown), Ruzeen Patwa, Xenia Kostoulias, Denis Korneev, Luke V. Blakeway, Nenad Maćešić, Anton Y. Peleg, Jeremy J. Barr	2
2	Hospital Enterococcus faecium demonstrates distinct environmental and patient reservoirs: a genomic point prevalence survey 2025 ·Infection Control and Hospital Epidemiology ·Nenad Maćešić, (unknown), Jessica A. Wisniewski, Luke V. Blakeway, (unknown), (unknown), Andrew J. Stewardson, Pauline Bass, (unknown), (unknown), (unknown), (unknown), Denis W. Spelman, Adam Jenney, Anton Y. Peleg	1
3	EHR-ML: A data-driven framework for designing machine learning applications with electronic health records 2025 ·International Journal of Medical Informatics ·(unknown), Nenad Maćešić, Geoffrey I. Webb, Anton Y. Peleg, Sonika Tyagi	5
4	Multidrug-resistant Gram-negative bacterial infections breakdown → 2025 ·The Lancet ·Nenad Maćešić, Anne‐Catrin Uhlemann, Anton Y. Peleg	48
5	Mechanisms of blaIMP-4 dissemination across diverse carbapenem-resistant clinical isolates 2025 ·Journal of Global Antimicrobial Resistance ·Ying Fu, Faye C. Morris, Stephanie Pereira, Xenia Kostoulias, Yan Jiang, (unknown), Gareth Williams, Yogitha N. Srikhanta, Nenad Maćešić, Yunsong Yu, Dena Lyras, Anton Y. Peleg	0
6	Genomic investigation of multispecies and multivariant bla_NDM outbreak reveals key role of horizontal plasmid transmission 2024 ·Infection Control and Hospital Epidemiology ·Nenad Maćešić, Adelaide S. M. Dennis, Jane Hawkey, Ben Vezina, Jessica A. Wisniewski, (unknown), Luke V. Blakeway, (unknown), (unknown), (unknown), Pauline Bass, Andrew J. Stewardson, (unknown), Denis W. Spelman, Adam Jenney, Anton Y. Peleg	2
7	Multidrug-resistant organism bloodstream infections in solid organ transplant recipients and impact on mortality: a systematic review 2024 ·JAC-Antimicrobial Resistance ·Alice Liu, Adelaide S. M. Dennis, (unknown), (unknown), Nenad Maćešić	2
8	Predicting Pseudomonas aeruginosa drug resistance using artificial intelligence and clinical MALDI-TOF mass spectra 2024 ·mSystems ·(unknown), Anton Y. Peleg, Jiangning Song, Bhavna Antony, Geoffrey I. Webb, Jessica A. Wisniewski, Luke V. Blakeway, (unknown), (unknown), (unknown), David L. Dowe, Nenad Maćešić	12
9	EHR-QC: A streamlined pipeline for automated electronic health records standardisation and preprocessing to predict clinical outcomes 2023 ·Journal of Biomedical Informatics ·(unknown), Nenad Maćešić, Geoffrey I. Webb, Anton Y. Peleg, Sonika Tyagi	6
10	Characterisation of key genotypic and phenotypic traits of clinical cystic fibrosis Staphylococcus aureus isolates 2023 ·Journal of Medical Microbiology ·(unknown), (unknown), Jhih‐Hang Jiang, Anton Y. Peleg, Luke V. Blakeway, Nenad Maćešić, Audrey Perry, Stephen Bourke, (unknown), Tracy Palmer	1
11	Genomic dissection of endemic carbapenem resistance reveals metallo-beta-lactamase dissemination through clonal, plasmid and integron transfer 2023 ·Nature Communications ·Nenad Maćešić, Jane Hawkey, Ben Vezina, Jessica A. Wisniewski, (unknown), Luke V. Blakeway, (unknown), (unknown), (unknown), (unknown), Denis W. Spelman, Adam Jenney, Anton Y. Peleg	24
12	Oral ciprofloxacin activity against ceftriaxone-resistantEscherichia coliin anin vitrobladder infection model 2022 ·Journal of Antimicrobial Chemotherapy ·Iain J. Abbott, (unknown), (unknown), Nenad Maćešić, Steven C. Wallis, Jason A. Roberts, Joseph Meletiadis, Anton Y. Peleg	3
13	Silent spread of mobile colistin resistance gene mcr-9.1 on IncHI2 ‘superplasmids’ in clinical carbapenem-resistant Enterobacterales 2021 ·Clinical Microbiology and Infection ·Nenad Maćešić, Luke V. Blakeway, James Stewart, Jane Hawkey, Kelly L. Wyres, Louise M. Judd, Ryan R. Wick, Adam Jenney, Kathryn E. Holt, Anton Y. Peleg	49
14	Baloxavir treatment of oseltamivir‐resistant influenza A/H1pdm09 in two immunocompromised patients 2020 ·Transplant Infectious Disease ·Nenad Maćešić, Jennifer Laplante, Justin G. Aaron, Emily DiMango, Benjamin A. Miko, Marcus R. Pereira, Ran Reshef, Kirsten St. George	10
15	CrrB Positively Regulates High-Level Polymyxin Resistance and Virulence in Klebsiella pneumoniae 2020 ·Cell Reports ·Thomas H. McConville, Medini K. Annavajhala, Marla J. Giddins, Nenad Maćešić, Carmen M. Herrera, Felix D. Rozenberg, (unknown), Danielle Ahn, Filippo Mancia, M. Stephen Trent, Anne‐Catrin Uhlemann	37
16	Reduced Mortality of Staphylococcus aureus Bacteremia in a Retrospective Cohort Study of 2139 Patients: 2007–2015 2019 ·Clinical Infectious Diseases ·Eloise D. Austin, (unknown), Nenad Maćešić, Monica Mehta, Benjamin A. Miko, Saman Nematollahi, Qiuhu Shi, Franklin D. Lowy, Anne‐Catrin Uhlemann	35
17	Colonizing multidrug-resistant bacteria and the longitudinal evolution of the intestinal microbiome after liver transplantation 2019 ·Nature Communications ·Medini K. Annavajhala, Angela Gomez‐Simmonds, Nenad Maćešić, Sean B. Sullivan, (unknown), Sabrina Khan, Marla J. Giddins, Stephania Stump, (unknown), (unknown), Elizabeth C. Verna, Anne‐Catrin Uhlemann	76
18	2262. Ceftazidime–Avibactam vs. Polymyxin B in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae 2019 ·Open Forum Infectious Diseases ·(unknown), Brian Nelson, Nenad Maćešić	4
19	Herpes simplex virus‐2 transmission following solid organ transplantation: Donor‐derived infection and transplantation from prior organ recipients 2017 ·Transplant Infectious Disease ·Nenad Maćešić, Iain J. Abbott, Matthew Kaye, Julian Druce, Allan R. Glanville, Paul Gow, Peter Hughes, Tony M. Korman, William R. Mulley, (unknown), Helen Opdam, Miranda Paraskeva, Matthew C. Pitman, (unknown), William D. Rawlinson, Paul D. R. Johnson	12
20	Hospital‐acquired influenza in an Australian sentinel surveillance system 2013 ·The Medical Journal of Australia ·Nenad Maćešić, Tom Kotsimbos, Paul Kelly, Allen Cheng	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact